MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-09-0002492
Market Cap
₹122 Cr
SHEEL-SM · NSE
Share Price
₹58.95
-1.83% today
Revenue
₹110 Cr
FY 2025-26 · +8.1% YoY
EBITDA
₹16.28 Cr
Margin 14.8%
Net Profit
₹11.79 Cr
FY 2025-26 · +13.3% YoY
P/E (TTM)
10.4x
P/B 1.0x
ROE
11.2%
ROCE 13.4%
Debt / Equity
0.12
Interest cover 12.6x
About Sheel Biotech Limited
Data last updated:
Sheel Biotech Limited is a public limited company based in New Delhi, Delhi, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 26 November 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1991PLC046531. Its GSTIN is 07AAACS1773R2ZS (Delhi). The company holds 13 GST registrations, of which 9 are active. It is a listed company as per MCA records. Its shares are listed on NSE: SHEEL.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.35 Cr. It was formerly known as Sheel Biotech Private Limited. It is led by directors including Divye Chandak (Managing Director) and Sanjay Chandak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Sheel Biotech Limited., 8 Balaji Estates 2nd Floor Block – C Guru Ravidas Marg Kalkaji, New Delhi, Delhi, India – 110019.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹110.02 Cr, a growth of 8.1% compared to the previous year. For the same year it recorded a net profit of ₹11.79 Cr (net margin 10.7%) and EBITDA of ₹16.28 Cr (EBITDA margin 14.8%). The net worth stands at ₹126.99 Cr (up 51.4% YoY). Total assets are valued at ₹136.55 Cr (up 34.1% YoY).
The company has about 53 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sheel Biotech. As per MCA filings, the company has open charges of ₹28.84 Cr and satisfied charges of ₹2.24 Cr on record. Court records list 80 cases involving the company, including 54 filed by the company and 26 filed against it; 10 cases are pending. The company has 18 deals on record (15 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹4.54 Cr; the latest was in October 2025.
Sheel Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0002492). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sheelbiotech.com.
Company details
CIN U24239DL1991PLC046531
Registration Number 046531
Incorporation Date 26 November 1991
ROC Delhi
Listing Status Listed (NSE: SHEEL)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-09-0002492
CIN history
Sheel Biotech has one previous CIN (Corporate Identification Number): L24239DL1991PLC046531. The current CIN is U24239DL1991PLC046531, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239DL1991PLC046531 | Current |
| L24239DL1991PLC046531 | Previous |
Key People
Divye Chandak Managing Director Sanjay Chandak Director Ramesh Chandra Srivastava Director Recognitions & Rankings of Sheel Biotech
Contact details
Sheel Biotech Limited's registered office is in New Delhi, Delhi. Its website is sheelbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSheel Biotech Limited., 8 Balaji Estates 2nd Floor Block – C Guru Ravidas Marg Kalkaji, New Delhi, Delhi, India – 110019
- IndustryLife Sciences, Biotechnology
To see the full contact details of Sheel Biotech Limited, buy the company report.
Comprehensive company report
Sheel Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sheel Biotech operates one associated brand: Sheel Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biotechnology, floriculture, greenhouse solutions, and agricultural services in India. | sheelbiotech.com |
Business activity
The main business activity of Sheel Biotech is agriculture, forestry, fishing. In detail, this covers support activities to agriculture and other activities including hunting.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A4 | Support activities to agriculture and Other Activities including hunting |
To see the full business activity and turnover split of Sheel Biotech Limited, buy the company report.
Financials of Sheel Biotech Limited
FY 2025-26 filings availableSheel Biotech Limited reported revenue of ₹110.02 Cr (up 8.1% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹110 Cr
+8.1% YoY
EBITDA
₹16.28 Cr
+8.8% YoY
Profit After Tax
₹11.79 Cr
+13.3% YoY
Net Worth
₹127 Cr
+51.4% YoY
Total Assets
₹137 Cr
+34.1% YoY
Total Debt
₹8.98 Cr
-48.3% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 110 | 102 | 103 | 88.94 | 84.39 | 63.03 |
| Revenue growth | +8.1% | -1.3% | +15.9% | +5.4% | +33.9% | - |
| EBITDA | 16.28 | 14.97 | 14.44 | 8.83 | 6.36 | 6.52 |
| EBITDA margin | +14.8% | +14.7% | +14.0% | +9.9% | +7.5% | +10.3% |
| Profit before tax | 14.01 | 12.82 | 12.23 | 6.37 | 4.57 | 4.79 |
| Net profit | 11.79 | 10.41 | 10.45 | 5.08 | 4.45 | 4.69 |
| Net profit margin | +10.7% | +10.2% | +10.1% | +5.7% | +5.3% | +7.4% |
| EPS (₹) | 5.78 | 7.19 | 25.28 | 12.25 | 10.88 | 11.58 |
| Balance sheet | ||||||
| Total assets | 137 | 102 | 96.61 | 83.00 | 83.58 | 77.98 |
| Net worth | 127 | 83.87 | 72.69 | 63.54 | 59.75 | 56.71 |
| Total debt | 8.98 | 17.36 | 23.54 | 19.17 | 23.58 | 21.20 |
| Cash & bank | 2.18 | 0.46 | 0.60 | 0.21 | 0.31 | 0.46 |
| Net working capital | 119 | 89.60 | 86.05 | 72.01 | 73.85 | 69.65 |
| Cash flow | ||||||
| Cash from operations | (17.57) | 8.51 | (0.92) | 9.29 | 2.19 | - |
| Cash from investing | (6.57) | (2.18) | (0.25) | (2.18) | (2.12) | - |
| Cash from financing | 25.86 | (6.48) | 1.56 | (7.22) | (0.23) | - |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 110 | 102 | 103 | 88.94 | 84.39 | 63.03 |
| Revenue growth | +8.1% | -1.3% | +15.9% | +5.4% | +33.9% | - |
| Other income | 0.71 | 0.52 | 0.26 | 0.08 | 0.33 | 0.22 |
| Total expenses | 93.74 | 86.78 | 88.67 | 80.11 | 78.03 | 56.51 |
| Employee cost | 14.73 | 13.48 | 11.19 | 9.22 | 9.09 | 7.81 |
| EBITDA | 16.28 | 14.97 | 14.44 | 8.83 | 6.36 | 6.52 |
| EBITDA margin | +14.8% | +14.7% | +14.0% | +9.9% | +7.5% | +10.3% |
| Depreciation | 1.07 | 0.90 | 0.99 | 1.02 | 0.94 | 0.76 |
| Interest | 1.91 | 1.77 | 1.48 | 1.52 | 1.18 | 1.19 |
| Profit before tax | 14.01 | 12.82 | 12.23 | 6.37 | 4.57 | 4.79 |
| Tax | 2.26 | 2.06 | 1.78 | 1.29 | 0.09 | 0.00 |
| Net profit | 11.79 | 10.41 | 10.45 | 5.08 | 4.45 | 4.69 |
| Net profit margin | +10.7% | +10.2% | +10.1% | +5.7% | +5.3% | +7.4% |
| EPS (₹) | 5.78 | 7.19 | 25.28 | 12.25 | 10.88 | 11.58 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 20.35 | 14.95 | 4.14 | 4.14 | 4.14 | 4.14 |
| Reserves & surplus | 107 | 68.92 | 68.55 | 59.40 | 55.61 | 52.57 |
| Shareholders' funds (net worth) | 127 | 83.87 | 72.69 | 63.54 | 59.75 | 56.71 |
| Secured loans | 8.98 | 13.25 | 13.31 | 10.03 | 12.24 | 11.23 |
| Unsecured loans | 0.00 | 4.11 | 10.23 | 9.14 | 11.34 | 9.97 |
| Total debt | 8.98 | 17.36 | 23.54 | 19.17 | 23.58 | 21.20 |
| Total liabilities | 137 | 102 | 96.61 | 83.00 | 83.58 | 77.98 |
| Assets | ||||||
| Gross block | 23.99 | 21.27 | 20.16 | 19.87 | 18.57 | 7.55 |
| Net block | 9.48 | 7.49 | 7.23 | 7.93 | 7.65 | 7.55 |
| Capital work in progress | 3.45 | 0.00 | 0.00 | 0.00 | 0.14 | 0.00 |
| Investments | 0.79 | 0.79 | 0.80 | 0.80 | 0.80 | 0.01 |
| Inventories | 29.57 | 39.39 | 32.77 | 19.30 | 11.83 | 6.28 |
| Sundry debtors | 61.81 | 55.08 | 57.70 | 56.05 | 64.71 | 60.69 |
| Cash & bank balances | 2.18 | 0.46 | 0.60 | 0.21 | 0.31 | 0.46 |
| Loans & advances | 34.28 | 4.22 | 4.32 | 7.24 | 6.36 | 6.55 |
| Total current assets | 128 | 99.15 | 95.39 | 82.80 | 83.21 | 73.98 |
| Total current liabilities | 9.24 | 9.55 | 9.34 | 10.79 | 9.36 | 4.33 |
| Net working capital | 119 | 89.60 | 86.05 | 72.01 | 73.85 | 69.65 |
| Total assets | 137 | 102 | 96.61 | 83.00 | 83.58 | 77.98 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 0.46 | 0.60 | 0.21 | 0.31 | 0.46 | - |
| Net cash from operating activities | (17.57) | 8.51 | (0.92) | 9.29 | 2.19 | - |
| Net cash from investing activities | (6.57) | (2.18) | (0.25) | (2.18) | (2.12) | - |
| Net cash from financing activities | 25.86 | (6.48) | 1.56 | (7.22) | (0.23) | - |
| Net change in cash | 1.72 | (0.14) | 0.39 | (0.10) | (0.15) | - |
| Closing cash | 2.18 | 0.46 | 0.60 | 0.21 | 0.31 | - |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +8.1% | -1.3% | +15.9% | +5.4% | +33.9% | - |
| EBITDA growth | +8.8% | +3.7% | +63.5% | +38.8% | -2.5% | - |
| PBT growth | +9.3% | +4.8% | +92.0% | +39.4% | -4.6% | +9997.0% |
| Net income growth | +13.3% | -0.4% | +105.7% | +14.2% | -5.1% | - |
| Revenue CAGR (3Y) | +7.4% | +6.4% | +17.8% | - | - | - |
| EBITDA CAGR (3Y) | +22.6% | +33.0% | +30.4% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +10.7% | +10.6% | +10.1% | +5.7% | +5.3% | +7.6% |
| Return on capital employed | +13.4% | +14.7% | +15.3% | +9.5% | +7.1% | +7.7% |
| Return on net worth | +11.2% | +13.8% | +15.4% | +8.2% | +7.8% | +8.5% |
| Debt / equity | 0.12 | 0.26 | 0.31 | 0.35 | 0.38 | 0.37 |
| Long-term debt / equity | 0.03 | 0.10 | 0.14 | 0.19 | 0.22 | 0.21 |
| Interest cover | 12.56 | 12.58 | 11.00 | 19.46 | 21.77 | 20.66 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 4.86 | 4.91 | 5.15 | 4.63 | 6.46 | 8.35 |
| Inventory turnover | 3.19 | 2.82 | 3.96 | 5.71 | 9.32 | 10.04 |
| Debtors turnover | 1.88 | 1.80 | 1.81 | 1.47 | 1.35 | 1.04 |
| EPS (₹) | 5.78 | 7.19 | 25.28 | 12.25 | 10.88 | 11.58 |
| Dividend per share (₹) | 0.00 | 1.00 | 3.10 | 3.10 | 3.10 | 0.00 |
| Book value per share (₹) | 62.40 | 56.09 | 175.42 | 153.34 | 144.19 | 136.87 |
To see the full year-wise statements and ratios of Sheel Biotech Limited, buy the company report.
Board of directors of Sheel Biotech Limited
Sheel Biotech has 6 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divye Chandak Also directs: Berry Mart Private Limited, Jayshee Investments Private Limited | Managing Director | 22 Aug 2024 | 2 Years 2 Months | Current |
| Sanjay Chandak | Director | 12 Oct 2011 | 15 Years 0 Months | Current |
| Ramesh Chandra Srivastava | Director | 31 Mar 2023 | 3 Years 6 Months | Current |
| Atul Kumar | Director | 28 Aug 2024 | 2 Years 1 Months | Current |
| Mini Chadha | Director | 28 Aug 2024 | 2 Years 1 Months | Current |
| Shyamsundar Bang Also directs: Jubilant Bevco Limited, Jubilant Beverages Limited | Director | 28 Aug 2024 | 2 Years 1 Months | Current |
Auditor
Sheel Biotech Limited is audited by MANOJ SANGEETA AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ SANGEETA AND ASSOCIATES | FY 2023 | 021873N |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 72.30%, foreign institutional investors hold 0.00%, domestic institutional investors hold 9.50% and retail and other public shareholders hold 18.20%.
Sep 2026
QUARTER
72.30% Promoters
9.50% DII (Domestic Institutional)
18.20% Retail & Others
Promoter holding - history
Now 72.30% · Sep 2026High 72.30% · Jun 2026Low 72.30% · Jun 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | |
|---|---|---|
| Promoters | 72.30% | 72.30% |
| Public | 27.70% | 27.70% |
Charges & borrowings
Open charges
₹28.84 Cr
Satisfied charges
₹2.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Aug 2024 | 100964187 | Indian Overseas Bank | ₹17.25 Lakh | Open | |
| 29 Jul 2022 | 100606349 | Indian Overseas Bank | ₹16 Lakh | Open | |
| 16 Sep 2021 | 100485860 | Indian Overseas Bank | ₹51.21 Lakh | Open | |
| 24 Jun 2008 | 10115302 | Indian Overseas Bank | ₹28 Cr | Open | |
| 08 Sep 2023 | 100788433 | Indian Overseas Bank | ₹90 Lakh | Satisfied |
To see the full charge records of Sheel Biotech Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Sheel Biotech Limited has 18 deals on record (15 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹4.54 Cr; the latest was in October 2025.
Total deals
18
Secondary share transfers
15
Funding rounds
2
IPO
1
Disclosed funding
₹4.54 Cr
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2025 | IPO | ₹34.02 Cr | Investors: Bharat venture opportunities, Aarth AIF Growth Fund, Sanshi Fund |
| Nov 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Sumeet Chandak HUF, 3 individuals Seller: 4 individuals |
| Jan 2011 | Funding round | ₹2.52 Cr | Investors: Others-Sheel Biotech Limited, RRP Management Services Private Limited , Nakoda Ji Buildwell Ltd. |
To see the full deal history of Sheel Biotech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sheel Biotech Limited has 80 court cases on record: 54 filed by Sheel Biotech, 26 filed against it. 10 cases are pending and 70 are disposed.
Total cases
80
Filed by the company
54
Filed against the company
26
Pending
10
Disposed
70
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 69 | 24 | 9 |
| High courts | 10 | 2 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 80)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed against the company by Triveni Cargo Express India Private Limited Through Pramod Kumar Mishra | Disposed |
| District court, Udham Singh Nagar, Uttarakhand | Interim or miscellaneous application | Filed by the company against Uttarakhand Seeds and Tarai Development Corporation Ltd. | Disposed |
| High Court | Writ petition | Filed by the company against Saveer Biotech Ltd. 1442, Choudhary Hardhyan Marg, and 2 others | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against VPG Stores Pvt Ltd and 2 others | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against M/S Zeal Corporation India Pvt Ltd | Disposed |
To see the full case history of Sheel Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sheel Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sheel Biotech Limited has a workforce of 53 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
53
Active EPFO establishments
1
Employee growth
17.78%
GST
Sheel Biotech has 13 GST registrations: 9 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
13
Active
9
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACS1773R2ZS | Delhi | Active | 01 Jul 2017 |
| 06AAACS1773R1ZV | Haryana | Active | 01 Jul 2017 |
| 09AAACS1773R1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AAACS1773R1Z6 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sheel Biotech Limited, buy the company report.
Recent activity
Sheel Biotech Limited has 19 board changes on record since 2007: 6 appointments and 13 cessations. The latest: Sumeet Chandak ceased to be Director on 11 Sep 2024.
Filing
Sheel Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi.
AGM
Sheel Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Indian Overseas Bank of Rs. 28.00 Cr registered on 24 Jun 2008 with Charge ID 10115302 was modified on 10 Jun 2025.
Charges
A charge registered on 04 Dec 2020 via Charge ID 100397525 with Axis Bank Limited was fully satisfied on 04 Apr 2025.
Charges
A charge registered on 20 May 2021 via Charge ID 100451033 with Indian Overseas Bank was fully satisfied on 10 Jan 2025.
Ceased
Sumeet Chandak ceased to be Director.
Appointed
Atul Kumar was appointed as Director.
Appointed
Mini Chadha was appointed as Director.
Appointed
Shyamsundar Bang was appointed as Director.
Ceased
Atul Kumar ceased to be Director.
Appointed
Divye Chandak was appointed as Managing Director.
Ceased
Divye Chandak ceased to be Managing Director.
34 earlier events are in the company report.
Frequently asked questions
Sheel Biotech is an active public limited company based in New Delhi, Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 26 November 1991 (35+ years old) and is registered under CIN U24239DL1991PLC046531. Listed on NSE: SHEEL.
Sheel Biotech reported revenue of ₹110.02 Cr for FY 2025-26 (up 8.1% YoY) based on standalone financials.
Sheel Biotech has 6 current directors:
- Divye Chandak - Managing Director
- Sanjay Chandak - Director
- Ramesh Chandra Srivastava - Director
- Atul Kumar - Director
- Mini Chadha - Director
- Shyamsundar Bang - Director
The latest financial statements of Sheel Biotech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sheel Biotech is 07AAACS1773R2ZS, registered in Delhi. The company has 13 GST registrations in all, of which 9 are active and 4 are cancelled or inactive. Other active GSTINs include 06AAACS1773R1ZV (Haryana), 09AAACS1773R1ZP (Uttar Pradesh), 10AAACS1773R1Z6 (Bihar).
The CIN (Corporate Identification Number) of Sheel Biotech is U24239DL1991PLC046531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Sheel Biotech is a listed company as per MCA records. Its shares are listed on NSE (symbol: SHEEL).
Sheel Biotech has 80 court cases on record: 54 filed by the company and 26 filed against it. 10 are pending. Most are in the district courts.
Sheel Biotech was incorporated on 26 November 1991, making it 35+ years old. It is registered with the Registrar of Companies, Delhi.
Sheel Biotech has 18 deals on record (15 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹4.54 Cr; the latest was in October 2025.